Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,388

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Epidemiology of cardiovascular disease in China: current features and implications

Zhao, Dong, Liu, Jing, Wang, Miao, Zhang, Xingguang, Zhou, Mengge·2019·Nature Reviews Cardiology
DOI 10.1038/s41569-018-0119-4
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41569-018-0119-4

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 62

  1. Zhou, M. et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 387, 251–272 (2016). · DOI · Paper page
  2. Yang, G. et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 381, 1987–2015 (2013). · DOI · Paper page
  3. Wright, P. Yingkai Wu–obituary. Lancet 363, 575–575 (2004). · doi:10.1016/s0140-6736(04)15564-5
  4. Bothig, S. WHO MONICA project: objectives and design. Int. J. Epidemiol. 18, S29–S37 (1989). · DOI · Paper page
  5. Wu, Z. et al. Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, part I: morbidity and mortality monitoring. Circulation 103, 462–468 (2001). · DOI · Paper page
  6. Zhao, D. et al. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing project. Stroke 39, 1668–1674 (2008). · DOI · Paper page
  7. Tunstall-Pedoe, H. et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 353, 1547–1557 (1999). · DOI · Paper page
  8. Lewington, S. et al. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Intern. Med. 176, 524–532 (2016).
  9. Li, H. & Ge, J. Cardiovascular diseases in China: current status and future perspectives. Int. J. Cardiol. Heart Vasc. 6, 25–31 (2015). · DOI
  10. Li, Y. et al. Can China achieve a one-third reduction in premature mortality from non-communicable diseases by 2030? BMC Med. 15, 132 (2017). · DOI
  11. Volgman, A. S. et al. Atherosclerotic cardiovascular disease in South Asians in the United States: epidemiology, risk factors, and treatments: a scientific statement from the American Heart Association. Circulation 138, e1–e34 (2018). · DOI · Paper page
  12. Chinese Society of Cardiology of Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology. Chinese guidelines for prevention of cardiovascular diseases [Chinese]. Zhonghua Xin Xue Guan Bing Za Zhi 46, 10–25 (2018).
  13. Zhao, D., Liu, J., Xie, W. & Qi, Y. Cardiovascular risk assessment: a global perspective. Nat. Rev. Cardiol. 12, 301–311 (2015). · DOI
  14. Tunstall-Pedoe, H. et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90, 583–612 (1994). · DOI · Paper page
  15. Zhang, G. et al. Burden of ischaemic heart disease and attributable risk factors in China from 1990 to 2015: findings from the global burden of disease 2015 study. BMC Cardiovasc. Disord. 18, 18 (2018). · DOI
  16. Wang, W. et al. Prevalence, Incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation 135, 759–771 (2017). · DOI · Paper page
  17. Krishnamurthi, R. V. et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Glob. Health 1, e259–e281 (2013).
  18. Wang, C. et al. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry. J. Stroke Cerebrovasc. Dis. 23, 1157–1163 (2014). · DOI
  19. Gao, Q. et al. Use of oral anticoagulation among stroke patients with atrial fibrillation in China: the ChinaQUEST (Quality evaluation of stroke care and treatment) registry study. Int. J. Stroke 8, 150–154 (2013). · DOI
  20. Longde, W. et al. Fixed-dose combination treatment after stroke for secondary prevention in China: a national community-based study. Stroke 46, 1295–1300 (2015). · DOI
  21. Wang, X. et al. Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: Results from a national stroke screening survey. Int. J. Cardiol. 271, 92–97 (2018). · DOI
  22. Yang, X. et al. Atrial fibrillation is not uncommon among patients with ischemic stroke and transient ischemic stroke in China. BMC Neurol. 17, 207 (2017). · DOI
  23. Wang, W. et al. Trend of declining stroke mortality in China: reasons and analysis. Stroke Vasc. Neurol. 2, 132–139 (2017). · DOI
  24. Jiang, Y. et al. Construction of China cardiovascular health index. BMC Publ. Health 18, 937 (2018). · DOI
  25. GBD 2013 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet 386, 2145–2191 (2015). · DOI · Paper page
  26. Moran, A. et al. Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ. Cardiovasc. Qual. Outcomes 3, 243–252 (2010). · DOI · Paper page
  27. Moran, A. et al. The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China. BMC Publ. Health 8, 394 (2008). · DOI
  28. Brunstrom, M. & Carlberg, B. Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis. JAMA Intern. Med. 178, 28–36 (2018). · DOI · Paper page
  29. Rafique, A. M. et al. Optimal P2Y12 inhibitor in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a network meta-analysis. JACC Cardiovasc. Interv. 9, 1036–1046 (2016). · DOI
  30. Boyd, C. M. & Kent, D. M. Evidence-based medicine and the hard problem of multimorbidity. J. Gen. Intern. Med. 29, 552–553 (2014). · DOI
  31. Stefanidis, K. B., Askew, C. D., Greaves, K. & Summers, M. J. The effect of non-stroke cardiovascular disease states on risk for cognitive decline and dementia: a systematic and meta-analytic review. Neuropsychol. Rev. 28, 1–15 (2018). · DOI
  32. Stampfer, M. J. Cardiovascular disease and Alzheimer’s disease: common links. J. Intern. Med. 260, 211–223 (2006). · DOI · Paper page
  33. Amsterdam, E. A. et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. Circulation 130, 2354–2394 (2014). · DOI · Paper page
  34. Chinese Society of Cardiology, Editorial Board of Chinese Journal of Cardiology. CSC guidelines for the diagnosis and treatment of acute coronary syndromes in patients presenting without persistent ST-segment elevation [Chinese]. Chinese J. Cardiol. 5, 18 (2017).
  35. European Society of Cardiology. Recent hospitalization trends for acute myocardial infarction in Beijing. Eur. Heart J. 37, 3188–3189 (2016). · DOI
  36. Zhang, Q. et al. Recent trends in hospitalization for acute myocardial infarction in Beijing: increasing overall burden and a transition from ST-segment elevation to non-ST-segment elevation myocardial infarction in a population-based study. Medicine (Baltimore) 95, e2677 (2016). · doi:10.1097/md.0000000000002677
  37. Yang, Q. et al. Invasive management strategies and antithrombotic treatments in patients with non-ST-segment-elevation acute coronary syndrome in China: findings from the improving CCC project (Care for Cardiovascular Disease in China). Circ. Cardiovasc. Interv. 10, e004750 (2017). · DOI
  38. Gomez, C. R., Schneck, M. J. & Biller, J. Recent advances in the management of transient ischemic attacks. F1000Res 6, 1893 (2017). · DOI
  39. Wang, Y. et al. Prevalence, knowledge, and treatment of transient ischemic attacks in China. Neurology 84, 2354–2361 (2015). · DOI
  40. Wang, L. et al. Factors associated with delayed presentation in patients with TIA and minor stroke in China: analysis of data from the China National Stroke Registry (CNSR). Neurol. Res. 35, 517–521 (2013). · DOI
  41. Wang, M. et al. Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China. Circ. Cardiovasc. Qual. Outcomes 7, 78–85 (2014). · DOI
  42. Zhao, D. The epidemiology of coronary heart disease (CHD) in 16 provinces of China. Multi-province cooperative group of cardiovascular disease surveillance (MONICA Project) [Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 14, 10–13 (1993).
  43. Gao, Y. L. et al. Characteristics of out-of-hospital acute coronary heart disease deaths of Beijing permanent residents at the age of 25 or more from 2007 to 2009 [Chinese]. Chinese. J. Cardiol. 40, 4 (2012).
  44. Wan, H. et al. The epidemiology of out-of-hospital deaths due to acute coronary events in young Beijing adults [Chinese]. Zhonghua Nei Ke Za Zhi 51, 274–278 (2012).
  45. Shao, F., Li, C. S., Liang, L. R., Li, D. & Ma, S. K. Outcome of out-of-hospital cardiac arrests in Beijing. Resuscitation 85, 1411–1417 (2014). · DOI
  46. Liu, X. Improvement of treatment strategy for acute myocardial infarction by chest pain center and regional synergy system [Chinese]. Chinese Circul. J. 33, 830–832 (2018).
  47. Chinese Chest Pain Center Accreditation Working Committee. The impacts of the chest pain center accreditation on the efficacy of pre-hospital care in patients with ST-segment elevation myocardial infarction [Chinese]. Chinese J. Front. Med. Sci. 9, 11–15 (2017).
  48. Bennett, D. A. et al. Association of physical activity with risk of major cardiovascular diseases in Chinese men and women. JAMA Cardiol. 2, 1349–1358 (2017). · DOI · Paper page
  49. Chen, Z. et al. Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies. Lancet 386, 1447–1456 (2015). · DOI · Paper page
  50. Wang, Y. et al. Lifetime risk for cardiovascular disease in a Chinese population: the Chinese multi-provincial cohort study. Eur. J. Prev. Cardiol. 22, 380–388 (2015). · DOI
  51. Wang, Y. et al. Lifetime risk of stroke in young-aged and middle-aged Chinese population: the Chinese multi-provincial cohort study. J. Hypertens. 34, 2434–2440 (2016). · DOI
  52. Bi, Y. et al. Status of cardiovascular health in Chinese adults. J. Am. Coll. Cardiol. 65, 1013–1025 (2015). · DOI · Paper page
  53. Li, Y. et al. Potential impact of time trend of life-style factors on cardiovascular disease burden in China. J. Am. Coll. Cardiol. 68, 818–833 (2016). · DOI
  54. Wang, Z. et al. Status of hypertension in China: results from the China hypertension survey, 2012–2015. Circulation 137, 2344–2356 (2018). · DOI · Paper page
  55. Lu, J. et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet 390, 2549–2558 (2017). · DOI · Paper page
  56. Zhang, M. et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults. Int. J. Cardiol. 260, 196–203 (2018). · DOI · Paper page
  57. Li, J. et al. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data. Lancet 385, 441–451 (2015). · DOI · Paper page
  58. Stevens, W. et al. Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China. BMC Health Serv. Res. 16, 175 (2016). · DOI
  59. Lu, Y. et al. Comparison of prevalence, awareness, treatment, and control of cardiovascular risk factors in China and the United States. J. Am. Heart Assoc. 7, e007462 (2018).
  60. Xu, Y. et al. Prevalence and control of diabetes in Chinese adults. JAMA 310, 948–959 (2013). · DOI · Paper page
  61. Zhou, B. et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387, 1513–1530 (2016). · DOI · Paper page
  62. Su, M. et al. Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey. Lancet 390, 2559–2568 (2017). · DOI

Cited by

See all 1,388

Metadata

Authors
Zhao, D., Liu, J., Wang, M., Zhang, X., & Zhou, M.
Venue
Nature Reviews Cardiology
Publisher
Springer Science and Business Media LLC
Published
2018-11-22
Volume
16
Issue
4
Pages
203-212
ISSN
  • 1759-5002 (ISSN-L)
  • 1759-5010
DOI
10.1038/s41569-018-0119-4
OpenAlex
W2900621847
Cited by
1,388
References
9
FWCI
14.80
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epidemiology of cardiovascular disease in China: current features and implications. https://app.cochat.ai/papers/10.1038/s41569-018-0119-4
The paper
Zhao, D., Liu, J., Wang, M., Zhang, X., & Zhou, M. (2019). Epidemiology of cardiovascular disease in China: current features and implications. Nature Reviews Cardiology. https://doi.org/10.1038/s41569-018-0119-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.